Clinical Trials on Cystadenoma, Serous

Total 86625 results

Sidney Kimmel Cancer Center at Thomas Jefferson...
Novartis Pharmaceuticals

Completed

EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients

Head and Neck Neoplasms | Central Nervous System Neoplasms

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Brain and Central Nervous System Tumors

United States
University of Washington
National Cancer Institute (NCI)

Completed

Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma

Brain and Central Nervous System Tumors

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas

Brain Tumor | Central Nervous System Tumor

United States, Canada, Australia
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)
NCIC Clinical Trials Group

Completed

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors

Canada
Texas Children's Cancer Center
National Cancer Institute (NCI)

Completed

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors

United States
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors

Brain and Central Nervous System Tumors

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain

Brain and Central Nervous System Tumors

United States
European Organisation for Research and Treatment...

Completed

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Brain and Central Nervous System Tumors

France, Switzerland, Belgium, Germany, Italy, United Kingdom, Netherlands, Portugal, Slovakia
Johns Hopkins Bloomberg School of Public Health
Tropical Diseases Research Centre, Zambia; HarvestPlus; Canadian International... and other collaborators

Completed

Efficacy of β-carotene Biofortified Maize in Reducing Vitamin A Deficiency Among Children

Vitamin A Deficiency | Low Serum Retinol

Zambia
Children's Hospital Los Angeles

Unknown

Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors

Brain and Central Nervous System Tumors

United States, Canada, Australia, Switzerland, New Zealand
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Brain Metastases

Brain and Central Nervous System Tumors

United States
University of Southern Denmark
Odense University Hospital; University of Copenhagen; Region of Southern Denmark and other collaborators

Active, not recruiting

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

Quality of Life | Venous Thromboembolism | Non-small Cell Lung Cancer | Brain Metastases

Denmark
Blokhin's Russian Cancer Research Center

Unknown

Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) (EPITOC)

Ovarian Neoplasms | Ovarian Cancer | Chemotherapy | BRCA1 Mutation | BRCA2 Mutation | Serous Adenocarcinoma

Russian Federation
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

Female Contraception | Contraception
Wuhan Binhui Biotechnology Co., Ltd.

Recruiting

OH2 Oncolytic Viral Therapy in Central Nervous System Tumors

Central Nervous System Tumors

China
Massachusetts General Hospital

Active, not recruiting

Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment

Central Nervous System Neoplasms | Brain Tumor

United States
University of California, San Francisco
National Cancer Institute (NCI); Agenus Inc.; American Brain Tumor Association

Completed

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Brain and Central Nervous System Tumors

United States
University of Rochester

Completed

Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury

Brain Neoplasm

United States
Colorado Health Foundation

Unknown

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Brain and Central Nervous System Tumors

United States, Canada
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Brain and Central Nervous System Tumors

United States
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors

Brain and Central Nervous System Tumors

United States
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

Procarbazine in Treating Patients With Recurrent Brain Tumor

Brain and Central Nervous System Tumors

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Taurolidine in Treating Patients With Recurrent or Progressive Glioma

Brain and Central Nervous System Tumors

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

Brain and Central Nervous System Tumors

United States, Australia
Memorial Sloan Kettering Cancer Center
Columbia University

Completed

[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors

Brain Cancer | Gliomas

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Brain and Central Nervous System Tumors

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

A-protein Levels in Adult and Pediatric Brain Tumor Patients

Malignant Childhood Central Nervous System Neoplasm

United States
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Brain and Central Nervous System Tumors

United States
University of Colorado, Denver
National Cancer Institute (NCI)

Completed

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Brain and Central Nervous System Tumors

United States
Acibadem University

Recruiting

Comparing Machine Guided VR Based Training With Educator Guided Training in Metaverse

Virtual Reality | Serious Game | Advanced Cardiac Life Support

Turkey
University of Wisconsin, Madison
University of Alabama at Birmingham; National Institute on Aging (NIA); University... and other collaborators

Enrolling by invitation

A Communication Tool to Improve Communication in the ICU

Communication | Serious Injury

United States
Maastricht University Medical Center

Completed

BOOSTH: Promoting Physical Activity in Primary Schools in Combination With Serious Gaming

Physical Activity | Child Behavior | Serious Game | School Intervention

Netherlands
The Hospital for Sick Children
Solving Kids' Cancer

Completed

Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours

Solid Tumors | Central Nervous System Tumors

Canada, United States
West Virginia University

Withdrawn

OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

Central Nervous System Tumors

United States
John Yu
Blaze Bioscience Inc.

Recruiting

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Central Nervous System Tumor

United States
Children's Hospitals and Clinics of Minnesota

Completed

Laser Interstitial Thermal Therapy (LITT) for the Treatment of Pediatric Central Nervous System Tumors

Brain Tumor

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Recurrent Ovarian Germ Cell Tumor | Undifferentiated Ovarian Carcinoma | Ovarian Serous...

United States
W.L.Gore & Associates

Recruiting

The GORE® VIAFORT Vascular Stent Iliofemoral Study

Venous Leg Ulcer | Venous Stasis | Venous Stenosis | Venous Occlusion | Venous Ulcer | Venous Thromboses | Venous Disease | Vein Thrombosis | Vein Occlusion | Vein Disease

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors

Brain and Central Nervous System Tumors | Metastatic Cancer

United States
Duke University

Completed

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

Brain and Central Nervous System Tumors | Metastatic Cancer

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

Brain and Central Nervous System Tumors

United States
Dartmouth-Hitchcock Medical Center

Completed

Combination Chemotherapy for Patients With Brain Cancer

Brain and Central Nervous System Tumors

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors

United States
National Cancer Institute (NCI)

Completed

Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Phase 2 Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors

Advanced Solid Tumors Harboring NTRK Fusion | Primary Central Nervous System Tumors Harboring NTRK Fusion

China

Clinical Trials on Cystadenoma, Serous

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations